Research on Chronic Insomnia Disorder (R01)
National Institutes of Health · Opportunity PA-07-047
Multiple Receipt Dates - See Link to Full Announcement for details.
Who can apply
- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and State institutions of higher education
- Native American tribal governments (Federally recognized)
- Public housing authorities
- Native American tribal organizations (other)
- Nonprofits with 501(c)(3), other than higher education
- Nonprofits without 501(c)(3)
- Private institutions of higher education
- For-profit organizations other than small businesses
- Small businesses
- Others
Foreign institutions are eligible to apply. Faith-based or community-based organizations can apply.
About this opportunity
Purpose. Insomnia Disorder affects approximately 10% of adults in the U.S. and results in decreased work and academic performance, increased risk of accidents, increased health care costs, and increased risk of depression and other mental disorders. Given the public health significance of this problem, the NIH State-of-the-Science Conference on Manifestations and Management of Chronic Insomnia in Adults was held in June, 2005. The resulting conference statement outlined what is currently known and identified important future directions for insomnia-related research. The purpose of this funding opportunity announcement (FOA) is to encourage research that addresses the research needs outlined in this conference statement. Recommended areas for future research include genetic and neurobiologic mechanisms of insomnia, longitudinal studies of incidence and course of insomnia, improved measures of daytime functioning and quality of life resulting from insomnia, studies of insomnia in special populations, the impact of insomnia on the development of other disorders including depression, drug abuse, and chronic diseases, and the development and evaluation of treatment approaches and their dissemination. Research that translates basic science findings into novel clinical approaches is particularly encouraged.
Similar grants still open
| Opportunity | Agency | Deadline | Award ceiling | Eligible |
|---|---|---|---|---|
| Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development of Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional) | National Institutes of Health | August 18, 2026 23d left | — | Nonprofits |
| Research Projects to Enhance Applicability of Mammalian Models for Translational Research (R01 Clinical Trial Not Allowed) | National Institutes of Health | September 7, 2026 43d left | $499k | Nonprofits |
| Assay development and screening for discovery of chemical probes, drugs or immunomodulators (R01 Clinical Trial Not Allowed) | National Institutes of Health | September 7, 2026 43d left | — | Nonprofits |
| Substance Use/Substance Use Disorder Dissertation Research Award (R36 Clinical Trials Not Allowed) | National Institutes of Health | September 7, 2026 43d left | — | Nonprofits |